Rilmazafone is a synthetic pharmaceutical compound classified as a benzodiazepine prodrug. It has been studied for its pharmacological properties and is converted in the body into active metabolites. The compound has been the subject of scientific and clinical research and is identified by CAS No. 85815-37-8.
Chemical and regulatory requirements for the handling, storage, research, manufacture, distribution, and use of Rilmazafone vary by jurisdiction. Users should consult applicable laws, regulations, safety documentation, and manufacturer specifications before working with this compound.






Reviews
There are no reviews yet.